Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Endocrinology and Metabolism Clinics of North America
|
February 6, 2019
Management of Medullary Thyroid Cancer
David Viola, Rossella Elisei
Endocrine Development
|
September 19, 2014
Medullary thyroid carcinoma in children
David Viola, Cristina Romei, Rossella Elisei
Future Oncology (London, England)
|
August 2, 2013
Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer
David Viola, Virginia Cappagli, Rossella Elisei
Gene
|
May 12, 2012
An idic(15) associated with POF (premature ovarian failure): molecular cytogenetic definition of a case and review of the literature
Veronica Bertini, David Viola, Paolo Vitti, et al.
Endocrinology and Metabolism Clinics of North America
|
June 4, 2014
How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level
Rossella Elisei, Laura Agate, David Viola, et al.
Clinical Endocrinology
|
April 18, 2019
Risk of incident circulatory disease in patients treated for differentiated thyroid carcinoma with no history of cardiovascular disease
Konstantinos A Toulis, David Viola, George Gkoutos, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
October 19, 2016
Role of YAP-1 in Thyroid Tumor Progression and Outcome
Clara Ugolini, Nicla Borrelli, Cristina Niccoli, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 19, 2009
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy
Paolo Miccoli, Aldo Pinchera, Gabriele Materazzi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 30, 2016
Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience
Liborio Torregrossa, David Viola, Elisa Sensi, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 25, 2020
Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid Tumors
Loredana Lorusso, Cristina Romei, Paolo Piaggi, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Endocrinology and Metabolism Clinics of North America
|
February 6, 2019
Management of Medullary Thyroid Cancer
David Viola, Rossella Elisei
Endocrine Development
|
September 19, 2014
Medullary thyroid carcinoma in children
David Viola, Cristina Romei, Rossella Elisei
Future Oncology (London, England)
|
August 2, 2013
Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer
David Viola, Virginia Cappagli, Rossella Elisei
Gene
|
May 12, 2012
An idic(15) associated with POF (premature ovarian failure): molecular cytogenetic definition of a case and review of the literature
Veronica Bertini, David Viola, Paolo Vitti, et al.
Endocrinology and Metabolism Clinics of North America
|
June 4, 2014
How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level
Rossella Elisei, Laura Agate, David Viola, et al.
Clinical Endocrinology
|
April 18, 2019
Risk of incident circulatory disease in patients treated for differentiated thyroid carcinoma with no history of cardiovascular disease
Konstantinos A Toulis, David Viola, George Gkoutos, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
October 19, 2016
Role of YAP-1 in Thyroid Tumor Progression and Outcome
Clara Ugolini, Nicla Borrelli, Cristina Niccoli, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 19, 2009
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy
Paolo Miccoli, Aldo Pinchera, Gabriele Materazzi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 30, 2016
Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience
Liborio Torregrossa, David Viola, Elisa Sensi, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 25, 2020
Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid Tumors
Loredana Lorusso, Cristina Romei, Paolo Piaggi, et al.
Page
of 6